文献速递眼底病与葡萄膜炎眼整形与眼眶

结节病性葡萄膜炎缓解的预测因素识别

Remission in sarcoid uveitis: identification of predictive factors.
PubMed 文献 · Br J Ophthalmol · 2026-09-22

这项多中心回顾性研究纳入329例结节病性葡萄膜炎患者,随访至少3年,随访中位6.5年,98例(30%)达到缓解。基线黄斑水肿与缓解可能性降低相关(HR 0.594,95%CI 0.342–0.996,p=0.043),基线肺部受累与缓解可能性升高相关(HR 1.588,95%CI 1.047–2.419,p=0.032)。缓解后复发6/98例(6%),中位复发时间46个月,复发时以眼前葡萄膜炎为主(83%),解剖模式与初发相似。

要点

  • 约三分之一结节病性葡萄膜炎患者可达缓解,基线黄斑水肿延迟缓解,基线肺部受累促进缓解。
  • 缓解后复发少见(6%),中位46个月,复发多为前葡萄膜炎且模式与初发相似。
  • 随访中位6.5年,缓解定义为无临床症状且无治疗至少3年。

核心结论

  • 约1/3结节病性葡萄膜炎患者达到缓解,基线黄斑水肿与缓解可能性降低相关,基线肺部受累与缓解可能性升高相关。
  • 缓解后复发不常见,且复发时葡萄膜炎解剖模式通常与初发表现相似。

研究设计与样本

  • 多中心回顾性研究,纳入结节病性葡萄膜炎患者,要求最低随访3年。
  • 共纳入329例患者,女性62%,中位年龄53岁。
  • 缓解定义为无结节病临床症状至少3年且无治疗;采用Kaplan-Meier生存曲线和Cox比例风险模型分析预测因素。

主要发现

  • 98例(30%)患者在中位随访6.5年时达到缓解。
  • 基线黄斑水肿与缓解可能性降低独立相关(HR 0.594,95%CI 0.342–0.996,p=0.043)。
  • 基线肺部受累与缓解可能性升高独立相关(HR 1.588,95%CI 1.047–2.419,p=0.032)。
  • 缓解后复发见于6/98例(6%),中位复发时间为缓解后46个月。
  • 复发时83%为前葡萄膜炎,且解剖模式与初发表现相似。

关键数值与推荐

  • 缓解定义为无结节病临床症状至少3年且无治疗。
  • 统计学显著性设定为p<0.05。
  • 基线黄斑水肿:HR 0.594(95%CI 0.342–0.996,p=0.043)。
  • 基线肺部受累:HR 1.588(95%CI 1.047–2.419,p=0.032)。

临床怎么用

  • 对结节病性葡萄膜炎患者,基线存在黄斑水肿提示缓解可能延迟,需更密切随访和个体化治疗预期。
  • 基线肺部受累患者缓解可能性较高,可据此与患者沟通预后。
  • 缓解后仍需长期随访,因复发虽少见但可发生于缓解后约46个月,且多表现为前葡萄膜炎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify predictive factors of remission in patients with sarcoid uveitis and to evaluate recurrence rates and patterns following remission. METHODS: Multicentre retrospective study of patients with sarcoid uveitis and a minimum follow-up of 3 years. Remission was defined as the absence of clinical symptoms of sarcoidosis for at least 3 years without treatment. Remission-free Kaplan-Meier survival curves were constructed for selected variables. Cox proportional hazards model was then applied. HRs and 95% CIs were estimated for each variable. Statistical significance was set at the p<0.05 level. Rates and patterns of recurrence after remission were collected and compared with initial presentation. RESULTS: A total of 329 patients were included (62% female, median age 53 years). Remission occurred in 98 (30%) patients after a median follow-up of 6.5 years. Macular oedema at baseline was associated with a lower likelihood of remission (HR, 0.594, 95% CI 0.342 to 0.996, p=0.043), whereas pulmonary involvement at baseline was associated with a higher likelihood of remission (HR, 1.588, 95% CI 1.047 to 2.419, p=0.032). Recurrence after remission occurred in 6 of 98 patients (6%), with a median time to recurrence of 46 months after remission. At recurrence, patients predominantly had anterior uveitis (83%) and shared similar anatomical patterns with their initial presentation. CONCLUSIONS: Approximately one in three patients with sarcoid uveitis achieved remission. Macular oedema at baseline was associated with delayed remission, while lung involvement at baseline was associated with faster remission. Recurrence after remission was uncommon and typically mirrored the initial uveitis phenotype.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Siriphanh A, Jacquot R, Subtil F, et al. Remission in sarcoid uveitis: identification of predictive factors. Br J Ophthalmol. 2026. PMID: 41922096. doi:10.1136/bjo-2025-328902

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。